BIRC5 and cancer: Combining the survivin siRNA-based gene therapy with various therapeutic approaches, such as chemotherapy, radiotherapy, immunotherapy, and multimodal imaging technology, it is expected to overcome the limitations of single therapy and yield new breakthroughs and hope for cancer treatment.